These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6220495)

  • 1. Immune mechanisms in organ allograft rejection.
    Lowry RP; Gurley KE; Forbes RD
    Transplant Proc; 1982 Dec; 14(4):679-81. PubMed ID: 6220495
    [No Abstract]   [Full Text] [Related]  

  • 2. "The factor of immunization" in allograft rejection: carried by cytotoxic T cells, not helper-inducer T cells.
    Gurley KE; Hall BM; Dorsch SE
    Transplant Proc; 1986 Apr; 18(2):307-9. PubMed ID: 2938319
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune mechanisms in organ allograft rejection: IV. An overview of adoptive transfer studies on the pathogenesis of homograft rejection in the inbred rat.
    Lowry RP; Forbes RD
    Transplant Proc; 1985 Aug; 17(4):1963-5. PubMed ID: 3161226
    [No Abstract]   [Full Text] [Related]  

  • 4. The possible role of cytotoxic T cells in the mediation of first-set allograft rejection.
    Hall BM; Gurley KE; Dorsch SE
    Transplantation; 1985 Sep; 40(3):336-9. PubMed ID: 2930923
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune mechanisms in organ allograft rejection. II. T helper cells, delayed-type hypersensitivity, and rejection of renal allografts.
    Gurley KE; Lowry RP; Forbes RD
    Transplantation; 1983 Oct; 36(4):401-5. PubMed ID: 6226134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cytotoxic/suppressor cells and T helper cells in fine needle renal allograft aspirates during different phases of rejection.
    Taube D; Hobby P; Welsh K
    Proc Eur Dial Transplant Assoc; 1983; 20():309-14. PubMed ID: 6228940
    [No Abstract]   [Full Text] [Related]  

  • 7. The real meaning of changing peripheral blood helper to cytotoxic/suppressor cell ratio during renal allograft rejection.
    Kovithavongs T; Dossetor JB
    Transplant Proc; 1984 Dec; 16(6):1486-9. PubMed ID: 6239421
    [No Abstract]   [Full Text] [Related]  

  • 8. T cells and their products in host responsiveness to organ allografts.
    Tilney NL; Kupiec-Weglinski J; Strom TB
    Prog Clin Biol Res; 1986; 224():21-39. PubMed ID: 2948194
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
    Cranston D; Wood KJ; Carter NP; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal transplantation and arteriosclerosis in the transplanted organ].
    Yamada K
    Nihon Jinzo Gakkai Shi; 2004; 46(8):789-91. PubMed ID: 15645734
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats.
    Thornburg LE; Padberg WM; Towpik E; Tilney NL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1025-30. PubMed ID: 2968692
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
    Heidecke CD; Kupiec-Weglinski JW; Lear PA; Abbud-Filho M; Araujo JL; Araneda D; Strom TB; Tilney NL
    J Immunol; 1984 Aug; 133(2):582-8. PubMed ID: 6234351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells mediating allograft rejection.
    Hall BM; Dorsch SE
    Immunol Rev; 1984; 77():31-59. PubMed ID: 6232202
    [No Abstract]   [Full Text] [Related]  

  • 14. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human renal allograft and peripheral blood T lymphocyte subpopulations during the onset and treatment of rejection.
    Taube D; Welsh K; Hobby P; Williams DG
    Clin Nephrol; 1984 Sep; 22(3):127-32. PubMed ID: 6237816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloned helper and cytotoxic T lymphocytes as effector cells in adoptive immunotherapy of murine leukemia.
    Bookman MA; Horak E; de Graaf PW
    Prog Clin Biol Res; 1989; 288():141-9. PubMed ID: 2524069
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional analysis of TDTH and Tc cells infiltrating primary or secondary allografts.
    Stepkowski SM; Bitter-Suermann H; Duncan WR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):361-3. PubMed ID: 2978908
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T-helper 2 activation on transplant rejection in "low responder" rats.
    Ito T; Kamiike W; Nozaki S; Yamamoto S; Uchikoshi F; Tanaka S; Ito A; Moriguchi A; Nakata S; Shirakura R
    Transplant Proc; 1995 Feb; 27(1):501-2. PubMed ID: 7879078
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of T cytotoxic cells correlates with the immune status of organ allograft recipients.
    Ito T; Stepkowski SM
    Transplant Proc; 1989 Apr; 21(2):3282-5. PubMed ID: 2523606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.